# Simultaneous Labyrinthectomy and Cochlear Implantation for Patients with Single-Sided Ménière's Disease and Profound Sensorineural Hearing Loss

**Authors:** G. Doobe, A. Ernst, R. Ramalingam, P. Mittmann, I. Todt

PMC · DOI: 10.1155/2015/457318 · BioMed Research International · 2015-08-24

## TL;DR

A combined surgery of labyrinthectomy and cochlear implantation effectively treats vertigo and restores hearing in patients with Ménière's disease and severe hearing loss.

## Contribution

Demonstrates the efficacy of simultaneous labyrinthectomy and cochlear implantation for treating Ménière's disease and hearing loss.

## Key findings

- All patients experienced a complete reduction in dizziness after the combined surgery.
- Patients achieved a 69% mean monosyllabic speech understanding at 65 dB post-implant activation.
- The procedure successfully rehabilitated both the auditory and vestibular systems.

## Abstract

Objective. To investigate the treatment outcome of a simultaneous labyrinthectomy and cochlear implantation in patients with single-sided Ménière's disease and profound sensorineural hearing loss. Study Design. Prospective study. Method. Five patients with single-sided Ménière's disease with active vertigo and functional deafness were included. In all cases, simultaneous cochlear implantation combined with labyrinthectomy surgery was performed. The outcome has been evaluated by the Dizziness Handicap Inventory (DHI) and speech recognition. Results. The combined labyrinthectomy and cochlear implantation led in all patients to a highly significant reduction of dizziness up to a restitutio ad integrum. After activation of the cochlear implant and rehabilitation, a mean monosyllabic speech understanding of 69% at 65 dB was observed. Conclusion. For patients with single-sided Ménière's disease and profound sensorineural hearing loss the simultaneous labyrinthectomy and cochlear implantation are efficient method for the treatment of vertigo as well as the rehabilitation of the auditory system.

## Full-text entities

- **Diseases:** emotional disorders (MESH:D009358), Meniere's Disease (MESH:D008575), emotional disturbance (MESH:D014832), head movement (MESH:D006258), cochlear and vestibular impairment (MESH:D015834), hearing impairment (MESH:D034381), Vertigo (MESH:D014717), Dizziness (MESH:D004244), vestibulopathy (MESH:D065635), nausea (MESH:D009325), endolymphatic hydrops (MESH:D018159), Sensorineural Hearing Loss (MESH:D006319), single-sided deafness (MESH:D012640), deficit (MESH:D009461), deafness (MESH:D003638), canal occlusion (MESH:D001157), vestibular deficiency (MESH:D020338), Emotional deficit (MESH:D001289), Dandy syndrome (MESH:D003616), neural (MESH:D015441)
- **Chemicals:** lidocaine (MESH:D008012), Betahistine (MESH:D001621), steroids (MESH:D013256), gentamicin (MESH:D005839)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4561297/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4561297/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC4561297/full.md

---
Source: https://tomesphere.com/paper/PMC4561297